{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:13Z","timestamp":1788480553519,"version":"build-2803163510"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nrcardio.2015.32","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T13:20:00Z","timestamp":1426598400000},"page":"325-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Causes, assessment, and treatment of stent thrombosis\u2014intravascular imaging insights"],"prefix":"10.1038","volume":"12","author":[{"given":"Daniel S.","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik-Kyung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"BFnrcardio201532_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"U Sigwart","year":"1987","unstructured":"Sigwart, U., Puel, J., Mirkovitch, V., Joffre, F. & Kappenberger, L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N. Engl. J. Med. 316, 701\u2013706 (1987).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCINTERVENTIONS.110.960872","volume":"4","author":"A Roguin","year":"2011","unstructured":"Roguin, A. Stent: the man and word behind the coronary metal prosthesis. Circ. Cardiovasc. Interv. 4, 206\u2013209 (2011).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199101033240103","volume":"324","author":"PW Serruys","year":"1991","unstructured":"Serruys, P. W.  et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N. Engl. J. Med. 324, 13\u201317 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1161\/01.CIR.91.6.1676","volume":"91","author":"A Colombo","year":"1995","unstructured":"Colombo, A.  et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91, 1676\u20131688 (1995).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJM199408253310801","volume":"331","author":"PW Serruys","year":"1994","unstructured":"Serruys, P. W.  et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med. 331, 489\u2013495 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJM199408253310802","volume":"331","author":"DL Fischman","year":"1994","unstructured":"Fischman, D. L.  et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med. 331, 496\u2013501 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice, M. C.  et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 346, 1773\u20131780 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","volume":"107","author":"E Grube","year":"2003","unstructured":"Grube, E.  et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107, 38\u201342 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses, J. W.  et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349, 1315\u20131323 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone, G. W.  et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med. 350, 221\u2013231 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJMp048262","volume":"351","author":"NI Muni","year":"2004","unstructured":"Muni, N. I. & Gross, T. P. Problems with drug-eluting coronary stents\u2014the FDA perspective. N. Engl. J. Med. 351, 1593\u20131595 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jacc.2004.11.065","volume":"45","author":"R Moreno","year":"2005","unstructured":"Moreno, R.  et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J. Am. Coll. Cardiol. 45, 954\u2013959 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jacc.2004.11.064","volume":"45","author":"AA Bavry","year":"2005","unstructured":"Bavry, A. A., Kumbhani, D. J., Helton, T. J. & Bhatt, D. L. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis. J. Am. Coll. Cardiol. 45, 941\u2013946 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR14","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou, I.  et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293, 2126\u20132130 (2005).","journal-title":"JAMA"},{"key":"BFnrcardio201532_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jacc.2004.09.079","volume":"45","author":"AT Ong","year":"2005","unstructured":"Ong, A. T.  et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J. Am. Coll. Cardiol. 45, 947\u2013953 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","volume":"52","author":"P Wenaweser","year":"2008","unstructured":"Wenaweser, P.  et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J. Am. Coll. Cardiol. 52, 1134\u20131140 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMoa067193","volume":"356","author":"GW Stone","year":"2007","unstructured":"Stone, G. W.  et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med. 356, 998\u20131008 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa067722","volume":"356","author":"B Lagerqvist","year":"2007","unstructured":"Lagerqvist, B.  et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med. 356, 1009\u20131019 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","volume":"297","author":"EL Eisenstein","year":"2007","unstructured":"Eisenstein, E. L.  et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297, 159\u2013168 (2007).","journal-title":"JAMA"},{"key":"BFnrcardio201532_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"SB King","year":"2008","unstructured":"King, S. B.  et al. 2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 Writing Committee. Circulation 117, 261\u2013295 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR21","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns, W.  et al. Guidelines on myocardial revascularization. Eur. Heart J. 31, 2501\u20132555 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR22","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker, S.  et al. 2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS): developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35, 2541\u20132619 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR23","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip, D. E.  et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115, 2344\u20132351 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1056\/NEJMoa067731","volume":"356","author":"L Mauri","year":"2007","unstructured":"Mauri, L.  et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 356, 1020\u20131029 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","volume":"370","author":"C Stettler","year":"2007","unstructured":"Stettler, C.  et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370, 937\u2013948 (2007).","journal-title":"Lancet"},{"key":"BFnrcardio201532_CR26","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","volume":"6","author":"T Tada","year":"2013","unstructured":"Tada, T.  et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. JACC Cardiovasc. Interv. 6, 1267\u20131274 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.CIR.103.15.1967","volume":"103","author":"DE Cutlip","year":"2001","unstructured":"Cutlip, D. E.  et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103, 967\u20131971 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","volume":"5","author":"EJ Armstrong","year":"2012","unstructured":"Armstrong, E. J.  et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc. Interv. 5, 131\u2013140 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR29","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jcin.2012.06.013","volume":"5","author":"B Brodie","year":"2012","unstructured":"Brodie, B.  et al. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC Cardiovasc. Interv. 5, 1043\u20131051 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/euhj.2001.2707","volume":"23","author":"NG Uren","year":"2002","unstructured":"Uren, N. G.  et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur. Heart J. 23, 124\u2013132 (2002).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0735-1097(98)00249-6","volume":"32","author":"F Schiele","year":"1998","unstructured":"Schiele, F.  et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies\u2014with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guided STenting. J. Am. Coll. Cardiol. 32, 320\u2013328 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/01.CIR.0000043240.87526.3F","volume":"107","author":"PV Oemrawsingh","year":"2003","unstructured":"Oemrawsingh, P. V.  et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP study). Circulation 107, 62\u201367 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR33","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","volume":"115","author":"S Cook","year":"2007","unstructured":"Cook, S.  et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115, 2426\u20132434 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCINTERVENTIONS.108.778647","volume":"2","author":"RJ Russo","year":"2009","unstructured":"Russo, R. J.  et al. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID trial). Circ. Cardiovasc. Interv. 2, 113\u2013123 (2009).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/01.CIR.0000078636.71728.40","volume":"108","author":"E Cheneau","year":"2003","unstructured":"Cheneau, E.  et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108, 43\u201347 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jacc.2004.12.066","volume":"45","author":"K Fujii","year":"2005","unstructured":"Fujii, K.  et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J. Am. Coll. Cardiol. 45, 995\u2013998 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR37","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.jacc.2014.02.607","volume":"63","author":"M Nakano","year":"2014","unstructured":"Nakano, M.  et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study. J. Am. Coll. Cardiol. 63, 2510\u20132520 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0735-1097(01)01162-7","volume":"37","author":"Y Kobayashi","year":"2001","unstructured":"Kobayashi, Y.  et al. Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial: A Stent vs. Stent Ultrasound Remodeling Evaluation. J. Am. Coll. Cardiol. 37, 1329\u20131334 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jcin.2009.01.012","volume":"2","author":"N Gonzalo","year":"2009","unstructured":"Gonzalo, N.  et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable\/unstable angina: insights from optical coherence tomography. JACC Cardiovasc. Interv. 2, 445\u2013452 (2009).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR40","first-page":"128","volume":"3","author":"J Tanigawa","year":"2007","unstructured":"Tanigawa, J., Barlis, P. & Di Mario, C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 3, 128\u2013136 (2007).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcin.2012.09.017","volume":"6","author":"HG Bezerra","year":"2013","unstructured":"Bezerra, H. G.  et al. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention. JACC Cardiovasc. Interv. 6, 228\u2013236 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/eurheartj\/ehq066","volume":"31","author":"Y Ozaki","year":"2010","unstructured":"Ozaki, Y.  et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur. Heart J. 31, 1470\u20131476 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.113.000931","volume":"7","author":"N Foin","year":"2014","unstructured":"Foin, N.  et al. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition. Circ. Cardiovasc. Interv. 7, 180\u2013189 (2014).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/01.CIR.0000155607.54922.16","volume":"111","author":"K Tanabe","year":"2005","unstructured":"Tanabe, K.  et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111, 900\u2013905 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR45","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1161\/01.CIR.0000035239.90657.B1","volume":"106","author":"VM Shah","year":"2002","unstructured":"Shah, V. M., Mintz, G. S., Apple, S. & Weissman, N. J. Background incidence of late malapposition after bare-metal stent implantation. Circulation 106, 1753\u20131755 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR46","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0002-9149(99)00539-1","volume":"84","author":"MK Hong","year":"1999","unstructured":"Hong, M. K.  et al. Intravascular ultrasound comparison of chronic recoil among different stent designs. Am. J. Cardiol. 84, 1247\u20131250 (1999).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcin.2012.08.022","volume":"6","author":"Y Fujino","year":"2013","unstructured":"Fujino, Y., Attizzani, G. F., Nakamura, S., Costa, M. A. & Bezerra, H. G. Frequency-domain optical coherence tomography assessment of stent constriction 9 months after sirolimus-eluting stent implantation in a highly calcified plaque. JACC Cardiovasc. Interv. 6, 204\u2013205 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR48","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/01.CIR.0000074778.46065.24","volume":"107","author":"GS Mintz","year":"2003","unstructured":"Mintz, G. S., Shah, V. M. & Weissman, N. J. Regional remodeling as the cause of late stent malapposition. Circulation 107, 2660\u20132663 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR49","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2005.05.068","volume":"46","author":"J Ako","year":"2005","unstructured":"Ako, J.  et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J. Am. Coll. Cardiol. 46, 1002\u20131005 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.105.563403","volume":"113","author":"MK Hong","year":"2006","unstructured":"Hong, M. K.  et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113, 414\u2013419 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/hrt.2007.120154","volume":"94","author":"R Hoffmann","year":"2008","unstructured":"Hoffmann, R.  et al. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart 94, 322\u2013328 (2008).","journal-title":"Heart"},{"key":"BFnrcardio201532_CR52","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCULATIONAHA.109.906040","volume":"122","author":"N Guo","year":"2010","unstructured":"Guo, N.  et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation 122, 1077\u20131084 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR53","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/eurheartj\/ehn553","volume":"31","author":"AK Hassan","year":"2010","unstructured":"Hassan, A. K.  et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur. Heart J. 31, 1172\u20131180 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR54","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.CIR.0000116751.88818.10","volume":"109","author":"MK Hong","year":"2004","unstructured":"Hong, M. K.  et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 109, 881\u2013886 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR55","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani, R.  et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109, 701\u2013705 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/CIRCULATIONAHA.109.854398","volume":"120","author":"S Cook","year":"2009","unstructured":"Cook, S.  et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 120, 391\u2013399 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","volume":"5","author":"G Guagliumi","year":"2012","unstructured":"Guagliumi, G.  et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc. Interv. 5, 12\u201320 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka, F.  et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation 129, 211\u2013223 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR59","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1136\/hrt.2009.167759","volume":"95","author":"JS Kim","year":"2009","unstructured":"Kim, J. S.  et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 95, 1907\u20131912 (2009).","journal-title":"Heart"},{"key":"BFnrcardio201532_CR60","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3349\/ymj.2012.53.3.524","volume":"53","author":"BK Kim","year":"2012","unstructured":"Kim, B. K.  et al. Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents. Yonsei Med. J. 53, 524\u2013529 (2012).","journal-title":"Yonsei Med. J."},{"key":"BFnrcardio201532_CR61","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10554-011-9943-x","volume":"28","author":"JS Kim","year":"2012","unstructured":"Kim, J. S.  et al. Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation. Int. J. Cardiovasc. Imaging 28, 1281\u20131287 (2012).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"BFnrcardio201532_CR62","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/01.CIR.0000025585.63486.59","volume":"106","author":"PW Serruys","year":"2002","unstructured":"Serruys, P. W.  et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106, 798\u2013803 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/CIRCINTERVENTIONS.113.000797","volume":"7","author":"E Im","year":"2014","unstructured":"Im, E.  et al. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ. Cardiovasc. Interv. 7, 88\u201396 (2014).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR64","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/01.CIR.0000091115.05480.B0","volume":"108","author":"A Farb","year":"2003","unstructured":"Farb, A., Burke, A. P., Kolodgie, F. D. & Virmani, R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108, 1701\u20131706 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR65","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn, A. V.  et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115, 2435\u20132441 (2007).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR66","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","volume":"47","author":"J Kotani","year":"2006","unstructured":"Kotani, J.  et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J. Am. Coll. Cardiol. 47, 2108\u20132111 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR67","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.amjcard.2006.11.068","volume":"99","author":"M Takano","year":"2007","unstructured":"Takano, M.  et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am. J. Cardiol. 99, 1033\u20131038 (2007).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR68","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jacc.2007.09.070","volume":"51","author":"M Takano","year":"2008","unstructured":"Takano, M.  et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J. Am. Coll. Cardiol. 51, 968\u2013969 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR69","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.110.957118","volume":"3","author":"M Takano","year":"2010","unstructured":"Takano, M.  et al. Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography. Circ. Cardiovasc. Interv. 3, 476\u2013483 (2010).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR70","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1161\/ATVBAHA.113.301227","volume":"33","author":"C Malle","year":"2013","unstructured":"Malle, C.  et al. Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb. Vasc Biol. 33, 1376\u20131383 (2013).","journal-title":"Arterioscler Thromb. Vasc Biol."},{"key":"BFnrcardio201532_CR71","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9149(01)02285-8","volume":"89","author":"DL Walters","year":"2002","unstructured":"Walters, D. L.  et al. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am. J. Cardiol. 89, 491\u2013494 (2002).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR72","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jcmg.2009.01.011","volume":"2","author":"G Nakazawa","year":"2009","unstructured":"Nakazawa, G., Vorpahl, M., Finn, A. V., Narula, J. & Virmani, R. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc. Imaging 2, 625\u2013628 (2009).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"BFnrcardio201532_CR73","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","volume":"57","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa, G.  et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J. Am. Coll. Cardiol. 57, 1314\u20131322 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR74","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.amjcard.2010.07.031","volume":"106","author":"SJ Kang","year":"2010","unstructured":"Kang, S. J.  et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am. J. Cardiol. 106, 1561\u20131565 (2010).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR75","first-page":"552","volume":"21","author":"M Habara","year":"2009","unstructured":"Habara, M., Terashima, M. & Suzuki, T. Detection of atherosclerotic progression with rupture of degenerated in-stent intima five years after bare-metal stent implantation using optical coherence tomography. J. Invasive Cardiol. 21, 552\u2013553 (2009).","journal-title":"J. Invasive Cardiol."},{"key":"BFnrcardio201532_CR76","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1136\/heartjnl-2012-302019","volume":"98","author":"J Bennett","year":"2012","unstructured":"Bennett, J., Coosemans, M. & Adriaenssens, T. Very late bare metal stent thrombosis due to neoatherosclerotic plaque rupture: an optical coherence tomography finding. Heart 98, 1470 (2012).","journal-title":"Heart"},{"key":"BFnrcardio201532_CR77","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.coph.2012.07.015","volume":"12","author":"F Abtahian","year":"2012","unstructured":"Abtahian, F. & Jang, I. K. Optical coherence tomography: basics, current application and future potential. Curr. Opin. Pharmacol. 12, 583\u2013591 (2012).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrcardio201532_CR78","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/hrt.2010.194381","volume":"96","author":"J Hou","year":"2010","unstructured":"Hou, J.  et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study. Heart 96, 1187\u20131190 (2010).","journal-title":"Heart"},{"key":"BFnrcardio201532_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jacc.2009.08.032","volume":"55","author":"M Takano","year":"2009","unstructured":"Takano, M.  et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J. Am. Coll. Cardiol. 55, 26\u201332 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR80","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jcmg.2012.01.024","volume":"5","author":"JS Kim","year":"2012","unstructured":"Kim, J. S.  et al. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT. JACC Cardiovasc. Imaging 5, 1147\u20131155 (2012).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"BFnrcardio201532_CR81","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.amjcard.2012.05.027","volume":"110","author":"T Yonetsu","year":"2012","unstructured":"Yonetsu, T.  et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am. J. Cardiol. 110, 933\u2013939 (2012).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR82","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2169\/internalmedicine.53.2177","volume":"53","author":"M Amioka","year":"2014","unstructured":"Amioka, M.  et al. Causes of very late stent thrombosis investigated using optical coherence tomography. Intern. Med. 53, 2031\u20132039 (2014).","journal-title":"Intern. Med."},{"key":"BFnrcardio201532_CR83","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jcmg.2013.02.006","volume":"6","author":"SJ Kang","year":"2013","unstructured":"Kang, S. J.  et al. OCT analysis in patients with very late stent thrombosis. JACC Cardiovasc. Imaging 6, 695\u2013703 (2013).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"BFnrcardio201532_CR84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2013.10.002","volume":"170","author":"C Klersy","year":"2013","unstructured":"Klersy, C.  et al. Use of IVUS guided coronary stenting with drug eluting stent: a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int. J. Cardiol. 170, 54\u201363 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201532_CR85","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.113.003942","volume":"129","author":"B Witzenbichler","year":"2014","unstructured":"Witzenbichler, B.  et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation 129, 463\u2013470 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR86","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4244\/EIJV8I7A125","volume":"8","author":"F Prati","year":"2012","unstructured":"Prati, F.  et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention 8, 823\u2013829 (2012).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ahj.2012.09.017","volume":"165","author":"A Chieffo","year":"2013","unstructured":"Chieffo, A.  et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am. Heart J. 165, 65\u201372 (2013).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201532_CR88","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/157340309788166697","volume":"5","author":"R Rogacka","year":"2009","unstructured":"Rogacka, R., Latib, A. & Colombo, A. IVUS-guided stent implantation to improve outcome: a promise waiting to be fulfilled. Curr. Cardiol. Rev. 5, 78\u201386 (2009).","journal-title":"Curr. Cardiol. Rev."},{"key":"BFnrcardio201532_CR89","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.amjcard.2007.09.116","volume":"101","author":"T Yamaguchi","year":"2008","unstructured":"Yamaguchi, T.  et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am. J. Cardiol. 101, 562\u2013567 (2008).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR90","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0300-8932(09)71328-4","volume":"62","author":"N Gonzalo","year":"2009","unstructured":"Gonzalo, N.  et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. Rev. Esp. Cardiol. 62, 615\u2013624 (2009).","journal-title":"Rev. Esp. Cardiol."},{"key":"BFnrcardio201532_CR91","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1272\/jnms.78.340","volume":"78","author":"K Kato","year":"2011","unstructured":"Kato, K.  et al. Intracoronary imaging modalities for vulnerable plaques. J. Nippon. Med. Sch. 78, 340\u2013351 (2011).","journal-title":"J. Nippon. Med. Sch."},{"key":"BFnrcardio201532_CR92","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00392-014-0748-5","volume":"103","author":"S Nakamura","year":"2014","unstructured":"Nakamura, S.  et al. Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study. Clin. Res. Cardiol. 103, 1015\u20131021 (2014).","journal-title":"Clin. Res. Cardiol."},{"key":"BFnrcardio201532_CR93","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/heartjnl-2011-301164","volume":"98","author":"N Sambu","year":"2012","unstructured":"Sambu, N.  et al. Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry. Heart 98, 706\u2013711 (2012).","journal-title":"Heart"},{"key":"BFnrcardio201532_CR94","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.903955","volume":"122","author":"T Kimura","year":"2010","unstructured":"Kimura, T.  et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation 122, 52\u201361 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR95","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2007.04.082","volume":"50","author":"T Kubo","year":"2007","unstructured":"Kubo, T.  et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J. Am. Coll. Cardiol. 50, 933\u2013939 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR96","first-page":"304","volume":"25","author":"DT Wong","year":"2013","unstructured":"Wong, D. T., Soh, S. Y. & Malaiapan, Y. In-stent thrombosis due to neoatherosclerosis: insight from optical coherence tomography. J. Invasive Cardiol. 25, 304 (2013).","journal-title":"J. Invasive Cardiol."},{"key":"BFnrcardio201532_CR97","unstructured":"PRESTIGE Consortium. PREvention of late Stent Thrombosis by an Interdisciplinary Global European effort: PRESTIGE. Eur. Heart J. 35, 2128\u20132129 (2014)."},{"key":"BFnrcardio201532_CR98","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","volume":"47","author":"JR Nebeker","year":"2006","unstructured":"Nebeker, J. R.  et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 47, 175\u2013181 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR99","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","volume":"33","author":"GG Stefanini","year":"2012","unstructured":"Stefanini, G. G.  et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur. Heart J. 33, 1214\u20131222 (2012).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR100","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/eurheartj\/ehp480","volume":"31","author":"P Barlis","year":"2010","unstructured":"Barlis, P.  et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur. Heart J. 31, 165\u2013176 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR101","doi-asserted-by":"publisher","first-page":"f6530","DOI":"10.1136\/bmj.f6530","volume":"347","author":"EP Navarese","year":"2013","unstructured":"Navarese, E. P.  et al. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMJ 347, f6530 (2013).","journal-title":"BMJ"},{"key":"BFnrcardio201532_CR102","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","volume":"63","author":"T Palmerini","year":"2014","unstructured":"Palmerini, T.  et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J. Am. Coll. Cardiol. 63, 299\u2013307 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR103","doi-asserted-by":"publisher","first-page":"f6625","DOI":"10.1136\/bmj.f6625","volume":"347","author":"S Bangalore","year":"2013","unstructured":"Bangalore, S.  et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ 347, f6625 (2013).","journal-title":"BMJ"},{"key":"BFnrcardio201532_CR104","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jcmg.2014.06.018","volume":"7","author":"HM Garcia-Garcia","year":"2014","unstructured":"Garcia-Garcia, H. M.  et al. Assessing bioresorbable coronary devices: methods and parameters. JACC Cardiovasc. Imaging 7, 1130\u20131148 (2014).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"BFnrcardio201532_CR105","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","volume":"64","author":"J Wiebe","year":"2014","unstructured":"Wiebe, J., Nef, H. M. & Hamm, C. W. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J. Am. Coll. Cardiol. 64, 2541\u20132551 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR106","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","volume":"373","author":"PW Serruys","year":"2009","unstructured":"Serruys, P. W.  et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373, 897\u2013910 (2009).","journal-title":"Lancet"},{"key":"BFnrcardio201532_CR107","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4244\/EIJV4I4A77","volume":"4","author":"HM Garc\u00eda-Garc\u00eda","year":"2009","unstructured":"Garc\u00eda-Garc\u00eda, H. M.  et al. Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis: a substudy of the ABSORB clinical trial. EuroIntervention 4, 443\u2013448 (2009).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR108","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/eurheartj\/ehq458","volume":"32","author":"J Gomez-Lara","year":"2011","unstructured":"Gomez-Lara, J.  et al. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Eur. Heart J. 32, 294\u2013304 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201532_CR109","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4244\/EIJV9I11A217","volume":"9","author":"PW Serruys","year":"2014","unstructured":"Serruys, P. W.  et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 9, 1271\u20131284 (2014).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR110","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","volume":"371","author":"JA Ormiston","year":"2008","unstructured":"Ormiston, J. A.  et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371, 899\u2013907 (2008).","journal-title":"Lancet"},{"key":"BFnrcardio201532_CR111","doi-asserted-by":"publisher","unstructured":"Simsek, C.  et al. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. EuroIntervention http:\/\/dx.doi.org\/10.4244\/EIJY14M10_12.","DOI":"10.4244\/EIJY14M10_12"},{"key":"BFnrcardio201532_CR112","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jacc.2014.09.029","volume":"64","author":"A Karanasos","year":"2014","unstructured":"Karanasos, A.  et al. OCT Assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J. Am. Coll. Cardiol. 64, 2343\u20132356 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR113","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.110.970772","volume":"122","author":"PW Serruys","year":"2010","unstructured":"Serruys, P. W.  et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 122, 2301\u20132312 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR114","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.4244\/EIJV10I10A190","volume":"10","author":"UK Allahwala","year":"2015","unstructured":"Allahwala, U. K.,  et al. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. EuroIntervention 10, 1154\u20131159 (2015).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR115","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jcin.2011.03.020","volume":"4","author":"J Gomez-Lara","year":"2011","unstructured":"Gomez-Lara, J.  et al. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc. Interv. 4, 992\u20131001 (2011).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR116","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","volume":"58","author":"PW Serruys","year":"2011","unstructured":"Serruys, P. W.  et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J. Am. Coll. Cardiol. 58, 1578\u20131588 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR117","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCINTERVENTIONS.112.971549","volume":"5","author":"JA Ormiston","year":"2012","unstructured":"Ormiston, J. A.  et al. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ. Cardiovasc. Interv. 5, 620\u2013632 (2012).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR118","doi-asserted-by":"publisher","unstructured":"Bourantas, C. V.  et al. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data. EuroIntervention http:\/\/dx.doi.org\/10.4244\/EIJY14M10_06.","DOI":"10.4244\/EIJY14M10_06"},{"key":"BFnrcardio201532_CR119","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","volume":"7","author":"Y Onuma","year":"2014","unstructured":"Onuma, Y.  et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb everolimus-eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB Cohort B trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc. Interv. 7, 1400\u20131411 (2014).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR120","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcin.2013.07.007","volume":"7","author":"S Verheye","year":"2014","unstructured":"Verheye, S.  et al. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. JACC Cardiovasc. Interv. 7, 89\u201399 (2014).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR121","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","volume":"10","author":"D Capodanno","year":"2015","unstructured":"Capodanno, D.  et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 10, 1144\u20131153 (2015).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR122","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW van Werkum","year":"2009","unstructured":"van Werkum, J. W.  et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J. Am. Coll. Cardiol. 53, 1399\u20131409 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR123","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jcin.2014.04.017","volume":"7","author":"R Waksman","year":"2014","unstructured":"Waksman, R.  et al. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). JACC Cardiovasc. Interv. 7, 1093\u20131102 (2014).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201532_CR124","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0735-1097(96)00452-4","volume":"29","author":"I Moussa","year":"1997","unstructured":"Moussa, I.  et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J. Am. Coll. Cardiol. 29, 6\u201312 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR125","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.amjcard.2006.02.039","volume":"98","author":"DW Park","year":"2006","unstructured":"Park, D. W.  et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am. J. Cardiol. 98, 352\u2013356 (2006).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR126","first-page":"15","volume":"22","author":"A Rabinovitz","year":"2010","unstructured":"Rabinovitz, A.  et al. Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis. J. Invasive Cardiol. 22, 15\u201319 (2010).","journal-title":"J. Invasive Cardiol."},{"key":"BFnrcardio201532_CR127","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott, S. D.  et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001\u20132015 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201532_CR128","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","volume":"128","author":"PG Steg","year":"2013","unstructured":"Steg, P. G.  et al. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation 128, 1055\u20131065 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR129","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","volume":"109","author":"S Matetzky","year":"2004","unstructured":"Matetzky, S.  et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109, 3171\u20133175 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio201532_CR130","doi-asserted-by":"publisher","first-page":"CS5","DOI":"10.1016\/j.jacc.2005.06.020","volume":"46","author":"P Wenaweser","year":"2005","unstructured":"Wenaweser, P. & Hess, O. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J. Am. Coll. Cardiol. 46, CS5\u2013CS6 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR131","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jacc.2004.11.041","volume":"45","author":"E Ferrari","year":"2005","unstructured":"Ferrari, E., Benhamou, M., Cerboni, P. & Marcel, B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J. Am. Coll. Cardiol. 45, 456\u2013459 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR132","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jacc.2014.01.019","volume":"63","author":"GF Attizzani","year":"2014","unstructured":"Attizzani, G. F., Capodanno, D., Ohno, Y. & Tamburino, C. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition. J. Am. Coll. Cardiol. 63, 1355\u20131367 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201532_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2012.08.037","volume":"111","author":"S Kim","year":"2013","unstructured":"Kim, S.  et al. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography. Am. J. Cardiol. 111, 1\u20135 (2013).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201532_CR134","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ahj.2011.10.016","volume":"163","author":"JS Kim","year":"2012","unstructured":"Kim, J. S.  et al. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT). Am. Heart J. 163, 601\u2013607 (2012).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201532_CR135","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1253\/circj.CJ-09-0546","volume":"74","author":"JS Kim","year":"2010","unstructured":"Kim, J. S.  et al. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ. J. 74, 320\u2013326 (2010).","journal-title":"Circ. J."},{"key":"BFnrcardio201532_CR136","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10554-010-9729-6","volume":"27","author":"TH Kim","year":"2011","unstructured":"Kim, T. H.  et al. Long-term (\u22652 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results. Int. J. Cardiovasc. Imaging 27, 875\u2013881 (2011).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"BFnrcardio201532_CR137","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4244\/EIJV10I4A77","volume":"10","author":"T Adriaenssens","year":"2014","unstructured":"Adriaenssens, T.  et al. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial. EuroIntervention 10, 439\u2013448 (2014).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201532_CR138","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/MCA.0b013e328362b2e7","volume":"24","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J.  et al. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study. Coron. Artery Dis. 24, 431\u2013439 (2013).","journal-title":"Coron. Artery Dis."},{"key":"BFnrcardio201532_CR139","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2011.05.076","volume":"162","author":"S Li","year":"2013","unstructured":"Li, S.  et al. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography. Int. J. Cardiol. 162, 166\u2013171 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201532_CR140","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jcin.2012.05.012","volume":"5","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber, L.  et al. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study. JACC Cardiovasc. Interv. 5, 946\u2013957 (2012).","journal-title":"JACC Cardiovasc. Interv."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.32","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:28:21Z","timestamp":1650389301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":140,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnrcardio201532"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2015.32","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]},"assertion":[{"value":"17 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.-K.J. declares that he has received a research grant and honorarium from St. Jude Medical and research grants from Boston Scientific and Medtronic. D.S.O. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}